AYAsanka S. Yapa

Asanka S. Yapa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Asanka S. Yapa has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Rapid detection of AAV8 binding antibodies in gene therapy candidates: development of a point-of-care approach

    by Alexander Kozikowski, Qing Wang, Cheng Yang, Neil Gordon, Kristina M. Ciociola, Asanka Yapa, Claudia Villa, Paul Lambotte, Thomas Pisani, Javan Esfandiari, et al.

    Preexisting anti-AAV antibodies pose a significant challenge to the success of Adeno-associated Virus (AAV) mediated gene therapies, as they can diminish therapeutic effectiveness, restrict patient eligibility for treatment, and cause serious health issues during treatment. This study introduces the first point-of-care (POC) test for the rapid, quantitative detection of AAV8 binding antibodies in patients’ plasma, serum, and blood, leveraging Chembio’s Dual Path Platform (DPP) technology. The DPP AAV8 Total Antibody (TAb) assay delivers results within 20 min from sample addition, with a dynamic range of 0-32 µg/ml when evaluated with purified human polyclonal antibodies that bind to AAV8, with reasonable specificity and sensitivity relative to Chembio’s AAV8 TAb ELISA (R² = 0.90). Moreover, the assay demonstrated strong correlations with Chembio’s AAV8 neutralizing antibody (NAb) ELISA and cell-based NAb assays (R² = 0.97 in plasma) (Cell-based assay adapted from BioAgilytix EU protocol). This rapid and reliable test can facilitate the screening of potential gene therapy patients for pre-existing antibodies that bind to AAV8 and assess their suitability for AAV8-mediated gene therapy.

  • Open Access

    Early detection of non-small cell lung cancer in liquid biopsies by ultrasensitive protease activity analysis

    by Dinusha N. Udukala, Sebastian O. Wendel, Hongwang Wang, Asanka S. Yapa, Obdulia Covarrubias-Zambrano, Katharine Janik, Gary Gadbury, Deryl L. Troyer, Stefan H. Bossmann

    Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.